Cargando…
New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety
New 1′-homocarbanucleoside analogs with an optically active substituted bicyclo[2.2.1]heptane skeleton as sugar moiety were synthesized. The pyrimidine analogs with uracil, 5-fluorouracil, thymine and cytosine and key intermediate with 6-chloropurine (5) as nucleobases were synthesized by a selectiv...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651170/ https://www.ncbi.nlm.nih.gov/pubmed/31277334 http://dx.doi.org/10.3390/molecules24132446 |
_version_ | 1783438283482595328 |
---|---|
author | Tănase, Constantin I. Drăghici, Constantin Hanganu, Anamaria Pintilie, Lucia Maganu, Maria Volobueva, Alexandrina Sinegubova, Ekaterina Zarubaev, Vladimir V. Neyts, Johan Jochmans, Dirk Slita, Alexander V. |
author_facet | Tănase, Constantin I. Drăghici, Constantin Hanganu, Anamaria Pintilie, Lucia Maganu, Maria Volobueva, Alexandrina Sinegubova, Ekaterina Zarubaev, Vladimir V. Neyts, Johan Jochmans, Dirk Slita, Alexander V. |
author_sort | Tănase, Constantin I. |
collection | PubMed |
description | New 1′-homocarbanucleoside analogs with an optically active substituted bicyclo[2.2.1]heptane skeleton as sugar moiety were synthesized. The pyrimidine analogs with uracil, 5-fluorouracil, thymine and cytosine and key intermediate with 6-chloropurine (5) as nucleobases were synthesized by a selective Mitsunobu reaction on the primary hydroxymethyl group in the presence of 5-endo-hydroxyl group. Adenine and 6-substituted adenine homonucleosides were obtained by the substitution of the 6-chlorine atom of the key intermediate 5 with ammonia and selected amines, and 6-methoxy- and 6-ethoxy substituted purine homonucleosides by reaction with the corresponding alkoxides. No derivatives appeared active against entero, yellow fever, chikungunya, and adeno type 1viruses. Two compounds (6j and 6d) had lower IC(50) (15 ± 2 and 21 ± 4 µM) and compound 6f had an identical value of IC(50) (28 ± 4 µM) to that of acyclovir, suggesting that the bicyclo[2.2.1]heptane skeleton could be further studied to find a candidate for sugar moiety of the nucleosides. |
format | Online Article Text |
id | pubmed-6651170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66511702019-08-07 New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety Tănase, Constantin I. Drăghici, Constantin Hanganu, Anamaria Pintilie, Lucia Maganu, Maria Volobueva, Alexandrina Sinegubova, Ekaterina Zarubaev, Vladimir V. Neyts, Johan Jochmans, Dirk Slita, Alexander V. Molecules Article New 1′-homocarbanucleoside analogs with an optically active substituted bicyclo[2.2.1]heptane skeleton as sugar moiety were synthesized. The pyrimidine analogs with uracil, 5-fluorouracil, thymine and cytosine and key intermediate with 6-chloropurine (5) as nucleobases were synthesized by a selective Mitsunobu reaction on the primary hydroxymethyl group in the presence of 5-endo-hydroxyl group. Adenine and 6-substituted adenine homonucleosides were obtained by the substitution of the 6-chlorine atom of the key intermediate 5 with ammonia and selected amines, and 6-methoxy- and 6-ethoxy substituted purine homonucleosides by reaction with the corresponding alkoxides. No derivatives appeared active against entero, yellow fever, chikungunya, and adeno type 1viruses. Two compounds (6j and 6d) had lower IC(50) (15 ± 2 and 21 ± 4 µM) and compound 6f had an identical value of IC(50) (28 ± 4 µM) to that of acyclovir, suggesting that the bicyclo[2.2.1]heptane skeleton could be further studied to find a candidate for sugar moiety of the nucleosides. MDPI 2019-07-03 /pmc/articles/PMC6651170/ /pubmed/31277334 http://dx.doi.org/10.3390/molecules24132446 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tănase, Constantin I. Drăghici, Constantin Hanganu, Anamaria Pintilie, Lucia Maganu, Maria Volobueva, Alexandrina Sinegubova, Ekaterina Zarubaev, Vladimir V. Neyts, Johan Jochmans, Dirk Slita, Alexander V. New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety |
title | New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety |
title_full | New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety |
title_fullStr | New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety |
title_full_unstemmed | New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety |
title_short | New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety |
title_sort | new hsv-1 anti-viral 1′-homocarbocyclic nucleoside analogs with an optically active substituted bicyclo[2.2.1]heptane fragment as a glycoside moiety |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651170/ https://www.ncbi.nlm.nih.gov/pubmed/31277334 http://dx.doi.org/10.3390/molecules24132446 |
work_keys_str_mv | AT tanaseconstantini newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety AT draghiciconstantin newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety AT hanganuanamaria newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety AT pintilielucia newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety AT maganumaria newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety AT volobuevaalexandrina newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety AT sinegubovaekaterina newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety AT zarubaevvladimirv newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety AT neytsjohan newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety AT jochmansdirk newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety AT slitaalexanderv newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety |